Celecoxib inhibits proliferation and induces apoptosis via cyclooxygenase-2 pathway in human pancreatic carcinoma cells

Wu Gaosong , Yi Jilin , Di Fang , Zou Shengquan , Li Xingrui

Current Medical Science ›› 2005, Vol. 25 ›› Issue (13) : 42 -44.

PDF
Current Medical Science ›› 2005, Vol. 25 ›› Issue (13) : 42 -44. DOI: 10.1007/BF02831383
Article

Celecoxib inhibits proliferation and induces apoptosis via cyclooxygenase-2 pathway in human pancreatic carcinoma cells

Author information +
History +
PDF

Abstract

In order to evaluate the effects and mechanisms of celecoxib in inhibiting proliferation and inducing apoptosis on human pancreatic carcinoma cells, the anti-proliferative effect was measured by using methabenzthiazuron (MTT) assay. Cell cycle and apoptosis were analyzed by using flow cytometry (FCM), and the PGE2 levels in the supernatant of cultured pancreatic carcinoma cells were quantitated by enzyme-linked immunoabsordent assay (ELISA). Our results showed that celecoxib suppressed the production of PGE2 and inhibited the growth of JF-305 cells, and the anti-proliferative effect of celecoxib could be abolished by addition of PGE2. FCM revealed that celecoxib could inhibit proliferation and induce apoptosis by G1-S cell cycle arrest. It was concluded that cyclooxygenase-2 specific inhibitor celecoxib could inhibit proliferation and induced apoptosis of human pancreatic carcinoma cells via suppression of PGE2 production in vitro.

Keywords

pancreatic carcinoma / cell line / cyclooxygenase-2 / prostaglandin E2 / celecoxib

Cite this article

Download citation ▾
Wu Gaosong, Yi Jilin, Di Fang, Zou Shengquan, Li Xingrui. Celecoxib inhibits proliferation and induces apoptosis via cyclooxygenase-2 pathway in human pancreatic carcinoma cells. Current Medical Science, 2005, 25(13): 42-44 DOI:10.1007/BF02831383

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

WuG S, WangJ H, LiuZ Y, et al.. Expression of cyclooxygenase-1 and-2 in extra-hepatic cholangiocarcinoma. HBPD INT, 2002, 1: 429-429

[2]

ChengJ, ImanishiH, IijimaH, et al.. Expression of cyclooxygenase-2 and cytosolic phospholipase A(2) in the liver tissue of patients with chronic hepatitis and liver cirrhosis. Hepatol Res, 2002, 23: 185-185

[3]

YoshimiK, SingoT, MasahikoT, et al.. Cyclooxygenase-2 activity altered the cell-surface carbohydrate antigens on colon cancer cells and enhanced liver metastasis. Cancer Res, 2002, 62: 1567-1567

[4]

MeiZY, ShiZ, WangX H, et al.. Synthesis of COX-2 inhibitor celecoxib. Zhongguo Yiyao Gongye Zazhi (Chinese), 2000, 31: 433-433

[5]

LeungW K, ToK F, NgY P. Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer. Br J Cancer, 2001, 84: 335-335

[6]

TsujiiM, DuboisR N. Alteration in cellular adhesion and apoptosis in epithelial cells overexpression prostaglandin endoperoxide synthase-2. Cell, 1995, 83: 493-493

[7]

GiardielloF M, OfferhausG J, DuboisR N. The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. J Euro Can, 1995, 31A: 1071-1071

[8]

JacobyR F, ColeC E, TutschK, et al.. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos. Cancer Res, 2000, 60: 1864-1864

[9]

RichterM, WeissM, WeinbergerI, et al.. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors. Carcinogenesis, 2001, 22: 17-17

[10]

CharalambousD, SkinnerS A, O'BrienP E.. Sulindac inhibits colorectal tumor growth, but not prostaglandin synthesis in the rat. J Gastroenterol Hepatol, 1998, 13: 1195-1195

AI Summary AI Mindmap
PDF

77

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/